Key facts
- Notable investors include Teal Ventures, i2020 Accelerator.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Expert Systems (Biotechnology)
- ·The full record, as it builds
Funding rounds
No funding rounds for Expert Systems (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Expert Systems (Biotechnology)
Developer of an artificial intelligence-enabled platform designed for drug discovery. The company's platform combines human and artificial intelligence to select candidate drugs for clinical trials and research and covers all aspects of preclinical drug discovery, from target identification, selection, and virtual screening to pharmacokinetics, enabling users to capitalize on expanding biotech modalities.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2023
- Employees
- 8
- Website
- expertsystems.inc/
- Ownership
- Privately Held (backing)
Expert Systems (Biotechnology) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Expert Systems (Biotechnology) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Expert Systems (Biotechnology) in its N-PORT filings yet. We sweep new filings monthly.